Over-prescribing methylphenidate won’t be cured by autism-style assessmentsBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f6622 (Published 06 November 2013) Cite this as: BMJ 2013;347:f6622
- Sami Timimi, consultant child psychiatrist1
- 1Lincolnshire Partnership NHS Foundation Trust, Sleaford NG34 8GG, UK
As McClure points out, inability to halt the upward trend of stimulant prescription was a predictable outcome of the National Institute for Health and Care Excellence guideline on attention-deficit/hyperactivity disorder (ADHD).1 However, the guideline’s problems go deeper than having an insufficient mechanism for differentiating moderate from severe ADHD. By their own criteria, the guideline development group found little to support …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial